DeepMed Research

University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

Bio-availability of Rectal Artesunate in Children With Severe Falciparum Malaria

Phase 2

Completed

Conditions: Malaria

Interventions: Drug: Intrarectal artesunate
Drug: Intravenous artesunate
Drug: Intravenous quinine

First Posted Date: 2015-07-08

Last Posted Date: 2015-12-03

Lead Sponsor: University of Oxford

Target Recruit Count: 82

Registration Number: NCT02492178

Locations: 🇨🇩
Kinshasa School of Public Health, Kinshasa, Congo, The Democratic Republic of the

Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination

Phase 1

Completed

Conditions: Ebola Virus Disease

Interventions: Biological: ChAd3-EBO Z
Biological: MVA-EBO Z

First Posted Date: 2015-06-30

Last Posted Date: 2019-02-06

Lead Sponsor: University of Oxford

Target Recruit Count: 40

Registration Number: NCT02485912

Locations: 🇸🇳
Centre Hospitalier Universitaire le Dantec, Dakar, Senegal

A New Rehabilitation Treatment Following Stroke

Not Applicable

Completed

Conditions: Stroke

Interventions: Behavioral: A New Rehabilitation Treatment following Stroke

First Posted Date: 2015-06-26

Last Posted Date: 2017-11-17

Lead Sponsor: University of Oxford

Target Recruit Count: 17

Registration Number: NCT02482688

Locations: 🇬🇧
University of Oxford, Oxford, United Kingdom

Baby Vaccine Study (Sched3)

Phase 2

Completed

Conditions: Infectious Diseases

Interventions: Biological: DTaP/IPV/Hib vaccine
Biological: 13 valent Pneumococcal Conjugate Vaccine
Biological: Rotavirus vaccine
Biological: 4-component Meningococcal B vaccine
Biological: Meningococcal C/Hib vaccine (MenC/Hib vaccine)
Biological: Measles/Mumps/Rubella Vaccine (MMR vaccine)

First Posted Date: 2015-06-26

Last Posted Date: 2021-09-20

Lead Sponsor: University of Oxford

Target Recruit Count: 189

Registration Number: NCT02482636

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom

Understanding Liver Fat Metabolism: Studies to Understand the Role of Dietary Sugars on Liver Fat Metabolism

Not Applicable

Completed

Conditions: Hypertriglyceridaemia

Interventions: Other: Sugar study

First Posted Date: 2015-06-23

Last Posted Date: 2017-01-20

Lead Sponsor: University of Oxford

Target Recruit Count: 16

Registration Number: NCT02478541

Locations: 🇬🇧
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, United Kingdom

Biomarker Signature and Musculoskeletal Ultrasound Profile in Rheumatoid Arthritis Patients

Completed

Conditions: Rheumatoid Arthritis

Interventions: Other: Musculoskeletal Ultrasound Imaging
Other: Synovial biopsy
Other: Biological samples collection
Other: Questionnaires

First Posted Date: 2015-06-19

Last Posted Date: 2022-05-20

Lead Sponsor: University of Oxford

Target Recruit Count: 43

Registration Number: NCT02476084

Locations: 🇬🇧
Nuffield Orthopaedic Centre, Oxford, United Kingdom

Fmri-based Neurofeedback With Anxious Adolescents Study

Phase 1

Conditions: Anxiety

Interventions: Behavioral: questionnaires
Device: Functional magnetic resonance imaging w neurofeedback

First Posted Date: 2015-06-04

Last Posted Date: 2016-11-10

Lead Sponsor: University of Oxford

Target Recruit Count: 50

Registration Number: NCT02463136

Locations: 🇬🇧
University of Oxford, Oxford, Oxfordshire, United Kingdom

Arterolane-PQP Versus DHA-PQP in Uncomplicated Falciparum Malaria in Eastern Myanmar

Phase 2

Withdrawn

Conditions: Artemisinin-resistant
Uncomplicated Falciparum Malaria

Interventions: Drug: Dihydroartemisinin-piperaquine phosphate (Duocotexin)
Drug: Arterolane maleate-piperaquine phosphate (Synriam)

First Posted Date: 2015-06-03

Last Posted Date: 2015-11-03

Lead Sponsor: University of Oxford

Registration Number: NCT02461186

PK Study of Anti-TB Drugs

Phase 1

Completed

Conditions: Tuberculosis

Interventions: Drug: Isoniazid (H)
Drug: Rifampicin (R)
Drug: Pyrazinamide (Z)
Drug: Ethambutol (E)

First Posted Date: 2015-05-29

Last Posted Date: 2018-10-03

Lead Sponsor: University of Oxford

Target Recruit Count: 61

Registration Number: NCT02457208

Locations: 🇹🇭
Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand

A Study by the Tracking Resistance to Artemisinin Collaboration (TRAC)

Phase 2

Completed

Conditions: Malaria, Falciparum

Interventions: Drug: ACT
Drug: TACT

First Posted Date: 2015-05-25

Last Posted Date: 2018-05-09

Lead Sponsor: University of Oxford

Target Recruit Count: 1110

Registration Number: NCT02453308

Locations: 🇧🇩
College of Medicine Chittagong, Ramu, Bangladesh
🇮🇳
Ispat General hospital, Rourkela, India
🇲🇲
Pyin oo Lwin hospital, Pyin oo Lwin, Myanmar

and more 17 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy